[ad_1]
Chesterbrook, Pennsylvania, June 5, 2016 / PRNewswire / – – The institute, formerly known as the Johnson & Johnson Diabetes Institute, continues to focus on transforming diabetes care through first-clbad experiential knowledge transfer.
LifeScan, Inc. – a world leader in blood glucose monitoring – today announced the new LifeScan Diabetes Institute name and a new brand identity for the former Johnson & Johnson Diabetes Institute. The name change must clearly indicate the new owner of LifeScan. As previously announced, Platinum Equity, a leading private equity firm, finalized the acquisition of LifeScan and the Johnson & Johnson Institute on October 2, 2018.
For over ten years, the institute has transformed diabetes care and will continue to fulfill its mission of finding solutions to the worldwide diabetes epidemic through a transfer of diabetes. first-clbad and experimental knowledge. Since its inception in 2007, thousands of diabetes health professionals have received individual training from the institute, including live and on-demand webinars, personal programs, a series of videos from clinical responses, education, e – learning modules and Twitter chats. and reviews of the diabetes literature.
"The LifeScan Diabetes Institute provides healthcare professionals around the world with up-to-the-minute information on innovative practice models and ways to leverage existing diabetes technologies and tools, helping to improve care and support." patient outcomes, "said Amparo Gonzalez, Global Professional Professional and Relations Section Director, LifeScan Diabetes Institute. "For more than a decade, the LifeScan Diabetes Institute has been supporting healthcare professionals around the world, staying true to its mission, and looking forward to transforming diabetes care and improving the lives of patients over the next few decades." on our future and what we can achieve in the next chapter of our development. "
In addition to its new name, the LifeScan Diabetes Institute has unveiled a new brand identity, including a renewed website and a new logo that you can see here.
About LifeScan, Inc.
LifeScan, Inc. is a world leader in blood glucose monitoring, with the goal of helping people with diabetes to lead unrestricted lives. More than 20 million people around the world use OneTouch® products to help control their diabetes. In the United States, LifeScan is the leader in blood glucose monitoring. OneTouch® brand products are recommended by more endocrinologists, family physicians and pharmacists than any other brand. The OneTouch Verio® platform has proven accuracy over seven years on more than 70,000 clinical data points1. For more information, visit www.OneTouch.com.
About the LifeScan Diabetes Institute
The LifeScan Diabetes Institute, a global initiative that has transformed the treatment of diabetes over the last decade, is intended to provide world-clbad diabetes treatment solutions through a transfer world-clbad experiential knowledge. The institute offers a wide range of personal and online educational opportunities. Thousands of diabetes specialists have gone through individual training – including innovative and innovative practice models and ways to use existing technologies and tools for diabetes – to provide better patient care and better results for patients around the world.
Setford et al. "Seven-year monitoring of the clinical performance of a test strip product for blood glucose" (Seven-year monitoring of the clinical performance of a test product for blood glucose). Journal of Diabetes Science and Technology (2017) 1-85
Logo – https://mma.prnewswire.com/media/773811/lfscinstitute_Logo.jpg
Press contact:
Bridget Kimmel
215-688-6033
Original content from: LifeScan, Inc., transmitted by news aktuell
Source link
